Abstract:Abstract Introduction Alzheimer's disease (AD), the most common form of dementia in the US, affecting 6.5 million individuals with a total healthcare cost of $321 billion, is characterized by cognitive dysfunction, memory problems, and disrupted sleep. Mice are crucial for studying AD and sleep patterns in humans, but current methods for inducing sleep disruption have limitations such as wired telemetry, real-time monitoring challenges, and disrupting the mouse's home environment. Better tools are needed to maximize the potential of mouse models in AD and sleep research. Objectives: This study aims to fill this gap by developing a novel system of sleep deprivation in mice to explore the underlying mechanisms connecting sleep and AD. Methods This study utilized a combination of DSI Co. wireless telemetry, Spike-2 software from CED Co., and third-party olfactory controllers to achieve automatic sleep deprivation via air-puffs. C57BL/6J (B6) mice were utilized for validation of the behavioral state recording/sleep deprivation system and preliminary biological analyses. The system was employed to achieve sleep deprivation in mice for 9 hours, then blood and brain tissue were collected for subsequent genetic analysis. qPCR was then applied to determine the expression of genes of interest related to AD, which was utilized in combination with analysis of variance to elucidate significance. Results Behavioral state recordings indicate the system can accurately collect and analyze telemetry signals in real time then initiate an air-puff, which successfully wakes the animal. qPCR results indicate a significant decrease in DNA damage repair enzyme and an increase in inflammatory cytokine gene expression, relative to controls, following ~9 hours of sleep deprivation (p< 0.05). These results collectively indicate the progression of an AD-phenotype. Conclusion These preliminary results indicate this novel system of behavioral state recording and sleep deprivation in mice can be applied to successfully explore the underlying mechanisms connecting sleep and AD. Future studies will extend to further proteomic and epigenetic analyses and explore specific sleep stages in relation to AD-progression. Support (if any) Center for Therapeutic Innovation (CTI)

Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice

A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice

Orexin A peptidergic system: Comparative physiology, morphology and population between brains of nomal and Alzheimer’s disease mice

Selective Orexin 2 Receptor Blockade Alleviates Cognitive Impairments and the Pathological Progression of Alzheimer's Disease in 3xTg-AD Mice

Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism

Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article

Lateralized brunt of sleep deprivation on white matter injury in a rat model of Alzheimer's disease

Optogenetic targeting of cortical astrocytes selectively improves NREM sleep in an Alzheimer's disease mouse model

0274 Effect of aging on sleep architecture including a novel REM Behavior Disorder phenotype in the PS19 mouse model of tauopathy and effect of a dual orexin receptor antagonist

Pharmacological enhancement of slow-wave activity improves cognition and reduces amyloidosis at an early stage in a mouse model of Alzheimer's disease

0216 Behavioral State Recording & Sleep Deprivation in Mice to Explore the Underlying Mechanisms of Alzheimer’s Disease

Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice

0215 Optogenetic Rescue of Sleep Slows Alzheimer's Progression in a Mouse Model

Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease

Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles

Omaveloxolone Ameliorates Cognitive Deficits by Inhibiting Apoptosis and Neuroinflammation in APP/PS1 Mice

Orexin A improves the cognitive impairment induced by chronic intermittent hypoxia in mice

Clock/Sleep-Dependent Learning and Memory in Male 3xTg-AD Mice at Advanced Disease Stages and Extrinsic Effects of Huprine X and the Novel Multitarget Agent AVCRI104P3